- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01442012
Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery (PUCTURE-NVPO)
Randomized Clinical Trial to Evaluate the Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting (PONV) in Ambulatory Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prospective, randomized, comparative study.
The disease to be studied is Postoperative Nausea and Vomiting (PONV). PONV, described by some as "The Big Little Problem", has a great impact on patient´s satisfaction and the postoperative care needed. Considering the increase of outpatient surgery there is an expanding demand for effective PONV treatment to prevent delays in discharge or unplanned readmissions. The estimated annual costs of PONV in the U.S. per year are 100 million Dollars.
Approximately 75 million patients are anesthetized in the world annually. It is estimated that 20-30% of these patients experience PONV, reaching 80% in patients at high risk. This incidence of PONV has maintained despite the improvement in surgical and anesthetic techniques and advances in antiemetic pharmacology. Increasingly, acupuncture is becoming part of Western medicine as a complementary treatment. Acupuncture has been described to effectively reduce the symptoms of different diseases, including PONV.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: PAULA ORTIZ LUCAS, MD
- Phone Number: +34 665987652
- Email: paula.ortiz.lucas@gmail.com
Study Contact Backup
- Name: VALENTIN MARTIN, MD, PhD
- Email: CoordinadorG6@gmail.com
Study Locations
-
-
-
Madrid, Spain, 28040
- Recruiting
- Fundación Jiménez Díaz Hospital
-
Contact:
- PAULA ORTIZ LUCAS, MD
- Phone Number: +34 665987652
- Email: paula.ortiz.lucas@gmail.com
-
Principal Investigator:
- PAULA ORTIZ LUCAS, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients of both sexes, aged 18 years and older.
- ASA I-II patients who will undergo a surgical procedure under general anesthesia in an ambulatory setting.
- Patients who are anticipated to not require admission to the recovery room or intensive care unit.
- Patients who, according to clinical criteria of the acupuncturist physician, are likely to benefit from acupuncture.
- Patients with a sufficient educational level to complete the health questionnaires required in the study.
- Patients who have given their written informed consent to participate in the study.
Exclusion Criteria:
- Patients with any pathology that under medical discretion makes their participation in the study inadvisable.
- Patients who cannot respond to the questionnaires provided during the study.
- Patients with known hypersensitivity to the materials of the ear seeds.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group A
Patients receive cutaneous stimulation and self-stimulation of acupuncture points Pericardium 6, Heart 7 and Stomach 25
|
The investigators will use ear seeds to stimulate acupuncture points.
The seeds will be applied when the patients are in the preoperative room.
After the patients have been discharged, they will need to stimulate these points every eight hours for five minutes, and every time they have nausea and/or vomiting during the first three postoperative days.
|
Sham Comparator: Group B
Patients receive cutaneous stimulation and self-stimulation of acupuncture points Gall Bladder 34, Kidney 6 and Liver 3
|
The investigators will use ear seeds to stimulate acupuncture points.
The seeds will be applied when the patients are in the preoperative room.
After the patients have been discharged, they will need to stimulate these points every eight hours for five minutes, and every time they have nausea and/or vomiting during the first three postoperative days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of patients with a score <50 on the PONV Intensity Scale at 72 hours postoperatively.
Time Frame: 72 hours
|
The percentage of patients with a score <50 on the PONV Intensity Scale (defined as clinically not significant PONV) at 72 hours postoperatively will be assessed in the experimental and control group, respectively.
In the experimental group, patients receive cutaneous stimulation and self-stimulation of acupuncture points Pericardium 6, Heart 7 and Stomach 25.
In the control (placebo) group, patients receive cutaneous stimulation and self-stimulation of acupuncture points Gall Bladder 34, Kidney 6 and Liver 3.
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of patients with a score <50 on the PONV Intensity Scale at 6 and 24 hours postoperatively.
Time Frame: 6 and 24 hours
|
The percentage of patients with a score <50 on the PONV Intensity Scale (defined as clinically not significant PONV) at 6 und 24 hours postoperatively will be assessed in the experimental and control group, respectively.
In the experimental group, patients receive cutaneous stimulation and self-stimulation of acupuncture points Pericardium 6, Heart 7 and Stomach 25.
In the control (placebo) group, patients receive cutaneous stimulation and self-stimulation of acupuncture points Gall Bladder 34, Kidney 6 and Liver 3.
|
6 and 24 hours
|
Evaluation of the postoperative recovery outcome
Time Frame: 24 hours
|
Evaluation of the postoperative recovery outcome using the postoperative quality of recovery score QoR-40.
|
24 hours
|
Evaluation of perioperative pain
Time Frame: 72 hours
|
Evaluation of perioperative pain using the verbal numerical pain scale
|
72 hours
|
Assessment of the patient´s satisfaction with the perioperative care
Time Frame: 72 hours
|
Assessment of the patient´s satisfaction with the perioperative care using the Leiden perioperative patient satisfaction questionnaire (LPPSq)
|
72 hours
|
Assessment of costs and economic impact of the disease
Time Frame: 72 hours
|
Assessment of costs and economic impact of the disease quantifying the use of health and non-health resources
|
72 hours
|
Assessment of need for rescue antiemetic medication
Time Frame: 72 hours
|
Assessment of need for rescue antiemetic medication by quantifying the patients who need two or more drugs with antiemetic effect as rescue medication
|
72 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: PAULA ORTIZ LUCAS, MD, Grupo G6
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GE6-ACU-2011-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Nausea and Vomiting
-
Cukurova UniversityTarsus UniversityRecruitingNausea, Postoperative | Vomiting, Postoperative | APFEL RİSK SCORETurkey
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Spain, Philippines, Israel, Hong Kong, Thailand, United Kingdom, Hungary, Slovenia, Norway, Denmark
-
MonoSol RxCompletedNausea With Vomiting Chemotherapy-Induced | Nausea and Vomiting, PostoperativeIndia
-
Methodist Health SystemRecruitingNausea, Postoperative | Vomiting, PostoperativeUnited States
-
Yeungnam University College of MedicineCompletedPostoperative Nausea | Postoperative VomitingKorea, Republic of
-
Northwell HealthTerminatedPostoperative Pain | Postoperative Nausea | Postoperative VomitingUnited States
-
Hôpital Privé de Parly II - Le ChesnayCompletedPostoperative Nausea | Postoperative Vomiting | Postoperative EmesisFrance
-
Vestre VikenHF Kongsberg SykehusNorwegian Medical AssociationCompletedPostoperative Complications | Postoperative Pain | Postoperative Vomiting and Nausea | Mental Status Changes PostoperativeKazakhstan, Russian Federation
-
Oregon Health and Science UniversityCompletedPostoperative Vomiting and NauseaUnited States
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Hungary, Canada, Spain, Belgium, Germany
Clinical Trials on Ear seeds
-
Wake Forest University Health SciencesCompletedOpioid Use DisorderUnited States
-
Alpha Tau Medical LTD.Not yet recruitingCarcinoma of the Vulva | Recurrent Carcinoma of the Vulva
-
Alpha Tau Medical LTD.Not yet recruitingNon-metastatic Prostate Cancer | Locally Recurrent Prostate CancerIsrael
-
Alpha Tau Medical LTD.RecruitingMalignant TumorIsrael
-
University of Maryland, BaltimoreUniversity of Maryland, College ParkWithdrawn
-
Hospital Authority, Hong KongUnknownCerumen Impaction of Both EarsHong Kong
-
Sunnybrook Health Sciences CentreWest Penn Allegheny Health System; British Columbia Cancer AgencyCompleted
-
National Yang Ming UniversityCompleted
-
University of Sao PauloCompleted
-
Alpha Tau Medical LTD.RecruitingRecurrent Squamous Cell CarcinomaUnited States, Israel